Stay updated on Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now shown, replacing the prior v3.2.0. Other visible content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:36:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The funding/status notice at the bottom of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T06:51:43.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Results have been posted on 2025-07-14 and study record dates (First Submitted, Last Update, Primary Completion, Study Completion) have been updated. This update clarifies the current status and available outcome information for the trial.
    Difference
    0.4%
    Check dated 2025-11-03T20:50:45.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Summary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T04:57:39.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:57:44.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page has been updated to Revision: v3.0.2 (replacing v3.0.1). The Back to Top element was removed as a minor UI change; no substantive changes to core content, pricing, stock, or time slots were detected.
    Difference
    0.1%
    Check dated 2025-09-14T18:54:07.000Z thumbnail image

Stay in the know with updates to Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.